956 filings
Page 33 of 48
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
9 Feb 12
Arrowhead Reports Fiscal 2012 First Quarter Financial Results
12:00am
10-Q
2012 Q1
ARWR
Arrowhead Pharmaceuticals Inc.
Quarterly report
9 Feb 12
12:00am
424B3
ARWR
Arrowhead Pharmaceuticals Inc.
3 Feb 12
Prospectus supplement
12:00am
EFFECT
ARWR
Arrowhead Pharmaceuticals Inc.
30 Jan 12
Notice of effectiveness
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
26 Jan 12
Correspondence with SEC
12:00am
S-3/A
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration (amended)
26 Jan 12
12:00am
424B3
ARWR
Arrowhead Pharmaceuticals Inc.
13 Jan 12
Prospectus supplement
12:00am
424B3
ARWR
Arrowhead Pharmaceuticals Inc.
13 Jan 12
Prospectus supplement
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
13 Jan 12
Correspondence with SEC
12:00am
DEF 14A
ARWR
Arrowhead Pharmaceuticals Inc.
Definitive proxy
12 Jan 12
12:00am
S-3/A
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration (amended)
10 Jan 12
12:00am
EFFECT
ARWR
Arrowhead Pharmaceuticals Inc.
10 Jan 12
Notice of effectiveness
12:00am
S-3/A
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration (amended)
10 Jan 12
12:00am
EFFECT
ARWR
Arrowhead Pharmaceuticals Inc.
10 Jan 12
Notice of effectiveness
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
9 Jan 12
Correspondence with SEC
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
9 Jan 12
Correspondence with SEC
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
9 Jan 12
Correspondence with SEC
12:00am
8-K/A
ARWR
Arrowhead Pharmaceuticals Inc.
30 Dec 11
Index to Financial Statements
12:00am
PRE 14A
ARWR
Arrowhead Pharmaceuticals Inc.
Preliminary proxy
30 Dec 11
12:00am
UPLOAD
ARWR
Arrowhead Pharmaceuticals Inc.
29 Dec 11
Letter from SEC
12:00am